期刊文献+

激素联合抗组胺药治疗中重度过敏性鼻炎 被引量:6

Hormone and Anti-histamine Drugs Treat Middle and Severe Allergic Rhinitis
在线阅读 下载PDF
导出
摘要 [目的]评估激素联合抗组胺药治疗中重度过敏性鼻炎的临床疗效。[方法]156例随机分为两组,治疗组80例,对照组78例。治疗组布地奈德鼻喷剂联合盐酸氮卓斯汀鼻喷剂喷鼻。对照组布地奈德鼻喷剂喷鼻,同时口服开瑞坦半月,分别于治疗1周,2周,4周,对流涕,鼻塞,鼻痒,打喷嚏四项临床症状进行评估。[结果]治疗组于治疗1周,2周,4周的疗效分别为62.5%,73.5%,85%。对照组分别是46.2%,51.2%,64.1%。[结论]激素联合抗组胺药治疗中重度过敏性鼻炎疗效较好。 [Objective]To evaluate the clinical effect of hormone added with anti-histamine medicine on middle and severe allergic rhinitis.[Method]Randomly divide 156 cases into treatment group(80)and control group(78);the treatment group takes Budesonide nasal spray added with Azelastine nasal spray;the other group one Budesonide,and oral taking Clarityne for half month;respectively appraise symptoms at 1w,2w,4w.[Result]In treatment group,the cure effective rates at the appointed time were 62.5%,73.5%,85%;for control one,they were 46.2%,51.2%,64.1% respectively.[Conclusion]Hormone combined with anti-histamine medicine has good cure effect on middle and severe allergic rhinitis.
作者 方夏兰
出处 《浙江中医药大学学报》 CAS 2010年第2期227-228,共2页 Journal of Zhejiang Chinese Medical University
关键词 过敏性鼻炎 布地奈德鼻喷剂 盐酸氮卓斯汀鼻喷剂 allergic rhinitis Budesonide nasal spray Azelastine
  • 相关文献

参考文献2

二级参考文献22

  • 1Salib RJ, Howarth PH. Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf, 2003, 26: 863-893.
  • 2Beger WE, White MV, Rhinitis Study Group. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. Ann Allergy Asthma Immunol, 2003, 91: 205-211.
  • 3Pearlman DS, Grossman J, Meltzer EO. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol, 2003, 91: 258-262.
  • 4Lieberman PL, Settipane RA. Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis. Allergy Asthma Proc, 2003, 24: 95-105.
  • 5Sale M, Lyness W, Perhach J, et al. Lack of effect of coadministration of erythromycin with azelastine on pharmacokinetic or ECG parameters. Ann Allergy Asthma Immunol, 1996, 76: 91.
  • 6Morganroth J, Perhach JL, Lyness W, et al. Lack of effect of azelastine alone and coadministered with ketaconazole on electrocardiographic parameters. J Allergy Clin Immunol, 1995, 95: 282.
  • 7Ventura MT, Giuliano G, Di Corato R, et al. Modulation of eosinophilic chemotaxis with azelastine and budesonide in allergic patients. Immunopharmacol Immunotoxicol, 1998, 20:383-398.
  • 8Saengpanich S, Assanasen P, deTineo M, et al. Effects of intranasal azelastine on the response to nasal allergen challenge. Laryngoscope, 2002, 112: 47-52.
  • 9Kusters S, Schuligoi R, Huttenbrink KB, et al. Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells. Arzneimittelforschung, 2002, 52: 97-102.
  • 10Mosges R, Klimek L. Azelastine reduces mediators of inflammation in patients with nasal polyps. Allergy Asthma Proc, 1998, 19:379-383.

共引文献1769

同被引文献60

引证文献6

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部